CID 3035704

Saframycin s

Structural Information

Molecular Formula
C28H31N3O9
SMILES
CC1=C(C(=O)C2=C(C1=O)C[C@H]3[C@@H]4C5=C(C[C@@H](N4C)[C@@H](N3[C@H]2CNC(=O)C(=O)C)O)C(=O)C(=C(C5=O)OC)C)OC
InChI
InChI=1S/C28H31N3O9/c1-10-21(33)13-7-15-20-19-14(22(34)11(2)26(40-6)24(19)36)8-16(30(20)4)28(38)31(15)17(9-29-27(37)12(3)32)18(13)23(35)25(10)39-5/h15-17,20,28,38H,7-9H2,1-6H3,(H,29,37)/t15-,16+,17-,20+,28-/m0/s1
InChIKey
FKBKETJRCKZDAM-SDBDLDFRSA-N
Compound name
N-[[(1S,2S,10R,12S,13R)-12-hydroxy-7,18-dimethoxy-6,17,21-trimethyl-5,8,16,19-tetraoxo-11,21-diazapentacyclo[11.7.1.02,11.04,9.015,20]henicosa-4(9),6,15(20),17-tetraen-10-yl]methyl]-2-oxopropanamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

4
References

55
Patents

553.20605 Da
Monoisotopic Mass

-0.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 554.21333 229.3
[M+Na]+ 576.19527 237.9
[M+NH4]+ 571.23987 231.3
[M+K]+ 592.16921 234.8
[M-H]- 552.19877 227.3
[M+Na-2H]- 574.18072 222.0
[M]+ 553.20550 229.3
[M]- 553.20660 229.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe